Medication info
Ducapin Tablet 60/2.5 mg

Ducapin Tablet 60/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Aprogen Biosciences Co., Ltd.
Appearance
Yellow, round-cornered, film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300113 · Approved 2023.01.06

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.

Ingredients

Manufacturer
Aprogen Biosciences Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by Pimasartan monotherapy.

How to take

Adult dose

Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.

Precautions

This medication may cause serious harm or death to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients who have allergies to the ingredients of this medication, who are undergoing kidney dialysis, who have moderate to severe liver impairment, or who have biliary obstruction should not take this medication. Patients with low blood volume, low salt levels, compromised kidney function, renal artery hypertension, cardiac valve disease, primary aldosteronism, severe hypotension, and the elderly should take special care when using this medication. This medication may rarely cause side effects such as dizziness, headache, edema, urinary disorders, insomnia, and flushing, so if any of these symptoms occur, consult a healthcare professional. Symptoms of hypotension or electrolyte imbalance may occur, so particularly patients taking high doses of diuretics should closely monitor their blood pressure and condition when starting this medication or increasing the dosage. Patients with heart failure or poor kidney function should undergo regular blood tests due to the risk of elevated serum potassium levels. This medication may interact with other antihypertensives, certain diuretics, lithium, and non-steroidal anti-inflammatory drugs, so other medications being taken should be disclosed. It is advisable for pregnant and breastfeeding women not to take this medication and to consult with healthcare professionals if necessary. Safety in children and adolescents under 18 years has not been established, so use is not recommended. In case of overdose, symptoms such as hypotension or abnormal heart rhythms may occur, and immediate medical treatment should be sought. This medication should be kept out of reach of children and it is advised not to transfer it to other containers for safety.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial edema
  • peripheral edema
  • urinary disorders
  • insomnia
  • flushing
  • syncope
  • sedation
Show 219 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contractions
  • musculoskeletal rigidity
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colon carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of back pain
  • osteoarthritis
  • arthritis
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • cerebral infarction
  • fractures
  • chest pain
  • weakness
  • fatigue
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • hypertonia
  • sensory decrease
  • sensory abnormalities
  • peripheral neuropathy
  • taste abnormalities
  • tremors
  • extrapyramidal disorder
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • hyperglycemia
  • arthralgia
  • back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • mood changes
  • dyspnea
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • blood pressure drop
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin redness
  • maculopapular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • elevated serum potassium levels
  • increased serum creatinine
  • increased blood urea nitrogen
  • hypotension
  • loss of consciousness
  • dyspnea
  • drowsiness
  • blood pressure drop
  • pulmonary edema
  • blood pressure variability
  • edema
  • peripheral edema
  • facial swelling
  • fatigue
  • fever
  • neck/shoulder pain
  • muscle weakness
  • tendonitis
  • osteomyelitis
  • shoulder impingement syndrome
  • lateral epicondylitis
  • synovitis
  • sciatica
  • jaw pain
  • arthralgia
  • osteoporosis
  • myalgia
  • pharyngitis
  • upper respiratory tract infection
  • sputum
  • rhinitis
  • nosebleeds
  • bronchitis
  • sensory abnormalities
  • numbness
  • tremors
  • generalized muscle tension
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional gastrointestinal disorders
  • gastroenteritis
  • frequent urination
  • urinary incontinence
  • kidney stones
  • chronic renal failure
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • benign prostatic hyperplasia
  • scrotal pain
  • elevated blood pressure
  • fatty liver
  • localized inflammation
  • soft tissue inflammation
  • lymphadenopathy
  • postoperative pain
  • allergy
  • chills
  • nasal polyps
  • pneumonia
  • hemoptysis
  • exacerbation of rhinitis
  • asthma
  • pulmonary granuloma
  • abnormal chest X-ray
  • sputum
  • bronchitis
  • herpes zoster
  • fungal infection
  • abscess
  • bacterial infection
  • genital herpes
  • herpes labialis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that blocks light and air, preferably at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Yellow, round-cornered, film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.